84 related articles for article (PubMed ID: 2545639)
21. Inhibition of lipolysis by agents acting via adenylate cyclase in fat cells from infants and adults.
Marcus C; Sonnenfeld T; Karpe B; Bolme P; Arner P
Pediatr Res; 1989 Sep; 26(3):255-9. PubMed ID: 2555764
[TBL] [Abstract][Full Text] [Related]
22. The role of insulin-sensitive phosphodiesterase in insulin action.
Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the stimulatory effect of adrenaline and prostaglandin E1 on the human fat cell adenylate cyclase by adenosine.
Kather H; Simon B
Horm Metab Res; 1980 Apr; 12(4):169-72. PubMed ID: 7390397
[TBL] [Abstract][Full Text] [Related]
24. Correction by dexamethasone treatment of the altered lipolytic cascade induced by adrenalectomy in rat adipocytes.
de Mazancourt P; Giot J; Giudicelli Y
Horm Metab Res; 1990 Jan; 22(1):22-4. PubMed ID: 2155164
[TBL] [Abstract][Full Text] [Related]
25. Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity.
Kaartinen JM; Hreniuk SP; Martin LF; Ranta S; LaNoue KF; Ohisalo JJ
Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):17-22. PubMed ID: 1656938
[TBL] [Abstract][Full Text] [Related]
26. Regulation of cyclic AMP metabolism and lipolysis in isolated rat fat cells by insulin, N6-(phenylisopropyl) adenosine and 2',5'-dideoxyadenosine.
Fain JN; Li SY; Moreno FJ
J Cyclic Nucleotide Res; 1979; 5(3):189-96. PubMed ID: 225356
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of adenosine cyclic 3', 5'-monophosphate accumulation in fat cells by adenosine, N6-(phenylisopropyl) adenosine, and related compounds.
Fain JN
Mol Pharmacol; 1973 Sep; 9(5):595-604. PubMed ID: 4363014
[No Abstract] [Full Text] [Related]
28. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
Kather H; Scheurer A
Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
[TBL] [Abstract][Full Text] [Related]
29. Adenosine and muscarinic cholinergic receptors attenuate cyclic AMP accumulation by different mechanisms in 1321N1 astrocytoma cells.
Hughes AR; Harden TK
J Pharmacol Exp Ther; 1986 Apr; 237(1):173-8. PubMed ID: 2420967
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of cyclic AMP accumulation in hamster adipocytes with phosphatidic acid: differences and similarities with alpha adrenergic effects.
Schimmel RJ; Honeyman TW; McMahon KK; Serio R; Clark RB
J Cyclic Nucleotide Res; 1980; 6(6):437-49. PubMed ID: 6163805
[TBL] [Abstract][Full Text] [Related]
31. Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.
Barovsky K; Brooker G
Mol Pharmacol; 1985 Dec; 28(6):502-7. PubMed ID: 3001496
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
Hellmér J; Marcus C; Sonnenfeld T; Arner P
J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
[TBL] [Abstract][Full Text] [Related]
33. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of lipolysis and cyclic AMP accumulation in white fat cells by tetracycline.
Madison KC; Fain JN
Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):224-31. PubMed ID: 168821
[TBL] [Abstract][Full Text] [Related]
35. Effects of choroid plexus peptide IIF on adenylate cyclase and 3',5'-cyclic adenosine monophosphate in adipose tissue.
Rudman D
J Pharmacol Exp Ther; 1975 Dec; 195(3):532-9. PubMed ID: 172624
[TBL] [Abstract][Full Text] [Related]
36. Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis.
Londos C; Cooper DM; Schlegel W; Rodbell M
Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5362-6. PubMed ID: 214785
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.
D'Costa MA; Angel A
J Clin Invest; 1975 Jan; 55(1):138-48. PubMed ID: 162783
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
Shechter Y
Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of hormone-stimulated human fat cell-lipolysis by prostaglandin E2 and its synthetic analogue sulprostrone.
Kather H
Prostaglandins Leukot Med; 1982 May; 8(5):525-9. PubMed ID: 6954554
[TBL] [Abstract][Full Text] [Related]
40. Islet-activating protein discriminates the antilipolytic mechanism of insulin from that of other antilipolytic compounds.
Kather H; Aktories K; Schulz G; Jakobs KH
FEBS Lett; 1983 Sep; 161(1):149-52. PubMed ID: 6350045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
